Prostate cancer : testosterone suppression levels and Eligard® - Schulman, Claude (Elsevier, 2005)
European urology supplements, ISSN 1569-9056 vol. 4, iss. 5, July 2005
Keywords: farmacie a farmakologie; leuprolid; Antineoplastic Agents, Hormonal; urologie; testosteron; hormonální protinádorové látky; Testosterone; luteinizační hormon; Disease Management; Prostate-Specific Antigen; prostatický specifický antigen; management nemoci; andrologie; Luteinizing Hormone; nádory prostaty; onkologie; Prostatic Neoplasms; Leuprolide